Category: Clinical trial
Finalist in the Excellence in Clinical Trial Management Category Catalyst demonstrates unwavering commitment to clients, adapting and flexing with needs Wilmington, N.C., May 19, Read Now 
Traditional Site Networks Are Broken Building Real Site Relationships to Facilitate the Success of Early Phase Oncology Trials Oncology clinical Read Now 
Ensuring Flexibility when Approaching CTIS When Catalyst Oncology implements the European Union Clinical Trial Regulation (EU CTR) across Sponsor studies Read Now 
Catalyst Oncology FIH Rescue Study A clinical-stage biotech company with a critical startup milestone Catalyst Oncology transitioned full-service work from Read Now 
Global Full-service Phase III Ovarian Cancer Study Catalyst Oncology succeeds in delivering for late clinical-stage oncology biotech. While the biotech had experience Read Now 
Expanding Clinical Trial Diversity: A Catalyst Values Approach “Today, overall cancer clinical trial enrollment in the United States is 8% (6.3%‐7.0% at community Read Now 
A Reflection on the European Regulatory Framework Historically gaining regulatory approval across multiple countries within the European Union (EU) was segmented, excessively Read Now